Published in Clin Exp Immunol on May 01, 1995
Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome. Infect Immun (1997) 0.98
Comparison of whole blood and peripheral blood mononuclear cell gene expression for evaluation of the perioperative inflammatory response in patients with advanced heart failure. PLoS One (2014) 0.75
Increased plasma levels of interleukin-6 in sepsis. Blood (1989) 3.92
Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest (1991) 3.62
Circulating interleukin-1 and tumor necrosis factor in septic shock and experimental endotoxin fever. J Infect Dis (1990) 3.20
Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure. Immunol Rev (1991) 3.08
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest (1993) 2.79
Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem (1990) 1.94
Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med (1989) 1.83
C-reactive protein as a diagnostic test of sepsis in the critically ill. Anaesth Intensive Care (1991) 1.67
Effect of anaesthesia on the cytokine responses to abdominal surgery. Br J Anaesth (1994) 1.66
Interleukin 1 beta is localized in the cytoplasmic ground substance but is largely absent from the Golgi apparatus and plasma membranes of stimulated human monocytes. J Exp Med (1988) 1.66
Anticytokine strategies in the treatment of the systemic inflammatory response syndrome. JAMA (1993) 1.54
Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol (1991) 1.46
Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods (1992) 1.34
Mediators of septic shock: new approaches for interrupting the endogenous inflammatory cascade. Crit Care Med (1993) 1.24
Development and application of radioimmunoassays for interleukin-1 alpha and interleukin-1 beta. J Immunol Methods (1989) 1.20
Circulating cytokines: the tip of the iceberg? Circ Shock (1992) 1.13
Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell. Eur J Immunol (1992) 1.09
Signals involved in interleukin 1 synthesis and release by lipopolysaccharide-stimulated monocytes/macrophages. Cytokine (1990) 1.08
Cytokine measurements in septic shock. Ann Intern Med (1993) 0.97
A flow cytometric and immunofluorescence microscopic study of tumor necrosis factor production and localization in human monocytes. Cell Immunol (1989) 0.92
Septic shock in critically ill patients: aetiology, management and outcome. J Infect (1993) 0.91
Modulation of the endotoxin receptor (CD14) in septic patients. J Trauma (1992) 0.88
Mechanisms of cytokine cascade activation in patients with sepsis: normal cytokine transcription despite reduced CD14 receptor expression. Surgery (1993) 0.87
The detection of intracytoplasmic interleukin-1 alpha, interleukin-1 beta and tumour necrosis factor alpha expression in human monocytes using two colour immunofluorescence flow cytometry. J Immunol Methods (1992) 0.84
Interleukin-6 is a cofactor for the growth of myeloid cells from human bone marrow aspirates but does not affect the clonogenicity of myeloma cells in vitro. Br J Haematol (1990) 0.82
C-reactive protein and its cytokine mediators in intensive-care patients. Clin Chem (1993) 0.81
Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Bone Marrow Transplant (1993) 0.79
Rapid determination of cell-associated tumor necrosis factor production by flow cytometry. Lab Invest (1993) 0.78
Enumeration of interleukin-1 alpha and beta producing cells by flow cytometry. J Immunol Methods (1992) 0.77
Influence of collection and separation of blood samples on plasma IL-1, IL-6 and TNF-alpha concentrations. J Immunol Methods (1992) 1.34
Clinical applications of immunofixation: detection and quantitation of complement activation. J Clin Pathol (1980) 1.15
Measurement of serum proteins during attacks of ulcerative colitis as a guide to patient management. Gut (1979) 1.12
Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part I: Early transplant period. J Clin Pathol (1984) 1.10
Preparation of a calibration material for specific protein assay (SPS-01). Ann Clin Biochem (1984) 1.08
Paraproteinaemia in neurological disease: incidence, associations, and classification of monoclonal immunoglobulins. J Clin Pathol (1980) 1.03
The occurrence of protein-bound mixed disulfides in rat tissues. Biochim Biophys Acta (1973) 1.01
Antibody synthesis within the central nervous system: comparisons of CSF IgG indices and electrophoresis. J Clin Pathol (1983) 1.00
Value of serum C-reactive protein measurement in the management of bone marrow transplant recipients. Part II: Late post-transplant period. J Clin Pathol (1984) 1.00
Alterations of serum lipids in breast cancer: effects of disease activity, treatment, and hormonal factors. Clin Chem (1991) 0.99
Studies of the in vitro phosphorylation of chromatin non-histone proteins in isolated nuclei. Biochim Biophys Acta (1973) 0.95
Laboratory investigation of monoclonal gammopathy during 10 years of screening in a general hospital. J Clin Pathol (1987) 0.95
Flow cytometric investigation of peri-anaesthetic anaphylaxis using CD63 and CD203c. Anaesthesia (2005) 0.94
Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma. Br J Cancer (1998) 0.94
A cellulose acetate immunofixation technique. J Immunol Methods (1978) 0.92
Faecal tumour necrosis factor-alpha in individuals with HIV-related diarrhoea. AIDS (1996) 0.90
Identification of the paraproteins and clinical significance of more than one paraprotein and clinical significance of more than one paraprotein in serum of 56 patients. J Clin Pathol (1979) 0.89
Improved resolution of cellulose acetate membrane electrophoresis. Ann Clin Biochem (1987) 0.87
Comparative studies of serum and synovial fluid C reactive protein concentrations. Ann Rheum Dis (1987) 0.86
Total and allergen-specific IgE in relation to allergic response pattern following bone marrow transplantation. Clin Exp Immunol (1986) 0.86
Increased serum IgE concentrations during infection and graft versus host disease after bone marrow transplantation. J Clin Pathol (1984) 0.85
Immune changes in peripheral blood resulting from locally directed interleukin-2 therapy in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol (1993) 0.85
Gene therapy with autologous, interleukin 2-secreting tumor cells in patients with malignant melanoma. Hum Gene Ther (1999) 0.85
Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to Streptococcus pneumoniae serotype 14 and its capsular polysaccharide. Clin Exp Immunol (2002) 0.84
Hormonal factors associated with weight loss in patients with advanced breast cancer. Ann Clin Biochem (1991) 0.83
Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia. Br J Haematol (1998) 0.83
The use of Teflon cell culture bags to expand functionally active CD8+ cytotoxic T lymphocytes. J Immunol Methods (1999) 0.82
Cytokine gene expression in skin and lymphoid organs in graft versus host disease. J Clin Pathol (1993) 0.82
Plasma neopterin as an adjunct to C-reactive protein in assessment of infection. Clin Chem (1991) 0.82
Imaging and laboratory investigation in herpes simplex encephalitis. J Neurol Neurosurg Psychiatry (1999) 0.81
Studies on the toxicity and antitumour activity of prednimustine, a prednisolone ester of chlorambucil. Eur J Cancer (1977) 0.81
Some effects of chlorambucil on the chromatin of Yoshida ascites sarcoma cells. Cancer Res (1973) 0.81
The integrity of nuclear proteins following incubation of isolated nuclei in vitro. Eur J Biochem (1975) 0.80
Limitations of Pneumovax as a detection antigen in the measurement of serotype-specific antibodies by enzyme-linked immunosorbent assay. Ann Clin Biochem (2002) 0.79
Monitoring cytokine production in peripheral blood during acute graft-versus-host disease following allogeneic bone marrow transplantation. Bone Marrow Transplant (1993) 0.79
C3 and C4 complement components and acute phase proteins in late pregnancy and parturition. J Clin Pathol (1988) 0.79
GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase I trial in melanoma. Ann Oncol (2000) 0.78
Human CD8+ CTL recognition and in vitro lysis of herpes simplex virus-infected cells by a non-MHC restricted mechanism. Scand J Immunol (2002) 0.78
Incidental correction of severe IgA deficiency by displacement bone marrow transplantation. Bone Marrow Transplant (1991) 0.77
Asbestosis. Bronchoalveolar lavage fluid proteins and their relationship to pulmonary epithelial permeability. Chest (1985) 0.77
An optimised biphasic culture system for the generation of functional dendritic cells from patients with acute lymphoblastic leukaemia at presentation and in clinical remission. Leukemia (2001) 0.77
Some effects of chlorambucil on nuclear protein phosphorylation in the Yoshida ascites sarcoma. Chem Biol Interact (1977) 0.77
Investigation of alpha nascent polypeptide-associated complex functions in a human CD8(+) T cell ex vivo expansion model using antisense oligonucleotides. Immunology (2004) 0.76
The absorption, distribution and excretion of 3 H-chlorambucil in rats bearing the Yoshida ascites sarcoma. Br J Cancer (1971) 0.75
The effect of chlorambucil on nuclear protein synthesis in Yoshida ascites-sarcoma cells. Biochem J (1971) 0.75
A randomised dose escalation study of subcutaneous interleukin 2 with and without levamisole in patients with metastatic renal cell carcinoma or malignant melanoma. Br J Cancer (1996) 0.75
An assessment of myeloid colony-forming-cell generation in liquid human bone marrow cultures: influence of accessory cells and cytokines IL-1 alpha, beta and IL-6. Int J Exp Pathol (1993) 0.75
In vitro effects of HA-1A (Centoxin) on cytokine production in whole blood from intensive care unit patients. Br J Anaesth (1994) 0.75
Mechanisms in secondary hypogammaglobulinaemia. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.75
Who pioneered the use of alternative donors (and stem cells from peripheral blood) in bone marrow transplantation? Arch Dis Child (1991) 0.75
The effects of IgG and immune complexes on the endotoxin-induced cytokine response. Cytokine (1994) 0.75
The binding of (3H)chlorambucil to isolated nuclear proteins of the Yoshida ascites sarcoma. Biochem Soc Trans (1975) 0.75
The effects of chlorambucil on the utilization of exogenous thymidine by tumour cells. Biochem Pharmacol (1975) 0.75
Genetic bisalbuminaemia occurring together with myeloma. Ann Clin Biochem (1983) 0.75
The use of monoclonal subclass-specific antibodies in the investigation of IgG paraproteins in human serum. Clin Chim Acta (1985) 0.75
Immunological parameters in peripheral blood of patients with renal cell carcinoma before and after nephrectomy. Br J Urol (1994) 0.75
The use of alkaline-phosphatase conjugated second antibody for the enhancement of immunoprecipitation techniques on cellulose acetate membranes. J Immunol Methods (1985) 0.75
Hypocomplementaemic urticarial vasculitis associated with non-Hodgkin lymphoma and treatment with intravenous immunoglobulin. Br J Dermatol (2007) 0.75
Combined detection of phenotype and Y chromosome by immunoenzyme labelling and in situ hybridisation on peripheral lymphocytes. J Immunol Methods (1991) 0.75
[Primary and secondary antibody deficiencies]. Clin Ter (1984) 0.75
Expression of donor allergic response patterns by bone marrow transplant recipients. Lancet (1984) 0.75
The binding of [3H]chlorambucil to nuclear proteins of the Yoshida ascites sarcoma. Chem Biol Interact (1975) 0.75
More on immunofixation vs immunoelectrophoresis. Clin Chem (1984) 0.75
Effects of chlorambucil treatment on the rates of respiration and glycolysis in drug-sensitive and -resistant strains of the Yoshida ascites sarcoma. Biochem Pharmacol (1970) 0.75
Some effects of chlorambucil on the uptake and utilization of sulphydryl-containing compounds by tumour cells. Biochem Pharmacol (1973) 0.75
Normal serum immunoglobulin and albumin levels in adult Ghanaians compared with levels in adults in Europe. Trop Geogr Med (1980) 0.75
The phenotypic changes in tumour infiltrating lymphocytes and tumour cells following intra-arterial infusion of interleukin-2 in patients with squamous cell carcinoma. J Pathol (1995) 0.75